Table 1. Correlation of RORα and RORγ levels with pathomorphological features.
Nuclear RORα | Cytoplasmic RORα | Nuclear RORγ | Cytoplasmic RORγ | |
---|---|---|---|---|
Clark level (n=79) | r=−0.1952 p=0.0424 |
r=−0.2521 p=0.0125 |
r=−0.3238 p=0.0020 |
r=−0.4065 p=0.0001 |
Breslows thickeness (n=79) | NS | r=−0.1918 p=0.0485 |
r=−0.2777 p=0.0076 |
r=−0.3152 p=0.0028 |
pT (n=79) | r=−0.3364 p=0.0012 |
r=−0.2940 p=0.0043 |
r=−0.3696 p=0.0005 |
r=−0.3884 p=0.0002 |
pN (n=79) | r=−0.2810 p=0.0066 |
r=−0.2470 p=0.0152 |
r=−0.3428 p=0.0011 |
r=−0.3442 p=0.0011 |
Overall stage* (n=79) | r=−0.3134 p=0.0035 |
r=−0.3094 p=0.0039 |
r=−0.4977 p< 0.0001 |
r=−0.3857 p=0.0003 |
Overall stage** (n=79) | r=−0.3260 p=0.0017 |
r=−0.2868 p=0.0052 |
r=−0.4897 p<0.0001 |
r=−0.4410 p<0.0001 |
TILs (n=76)# | r=0.3589 p=0.0008 |
r=0.2213 p=0.0282 |
r=0.2623 p=0.0106 |
NS |
Ulceration (n=78)## | r=−0.3725 p=0.0004 |
r=−0.1635 p=0.0776 |
r=−0.4302 p< 0.0001 |
r=−0.3318 p=0.0016 |
Proliferative index (Ki-67 immunostaining) (n=74)### | NS | NS | NS | r=−0.2159 p=0.0333 |
assessed at the time of diagnosis
assessed during follow-up
NS- not statistically significant
missing data for 3 cases
missing data for 1 case
missing data for 5 cases